FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines
- PMID: 14527951
- DOI: 10.1074/jbc.M309523200
FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines
Abstract
Paclitaxel is used to treat breast cancers, but the mechanisms by which it induces apoptosis are poorly understood. Consequently, we have studied the role of the FoxO transcription factors in determining cellular response to paclitaxel. Western blotting revealed that in a panel of nine breast cancer cell lines expression of FoxO1a and FoxO3a correlated with the expression of the pro-apoptotic FoxO target Bim, which was associated with paclitaxel-induced apoptosis. In MCF-7 cells, which were paclitaxel-sensitive, the already high basal levels of FoxO3a and Bim protein increased dramatically after drug treatment, as did Bim mRNA, which correlated with apoptosis induction. This was not observed in MDA-231 cells, which expressed low levels of FoxOs and Bim. Gene reporter experiments demonstrated that in MCF-7 cells maximal induction of Bim promoter was dependent on a FoxO binding site, suggesting that FoxO3a is responsible for the transcriptional up-regulation of Bim. Gene silencing experiments showed that small interference RNA (siRNA) specific for FoxO3a reduced the levels of FoxO3a and Bim protein as well as inhibited apoptosis in paclitaxel-treated MCF-7 cells. Furthermore, siRNA specific for Bim reduced the levels of Bim protein and inhibited apoptosis in paclitaxel-treated MCF-7 cells. This is the first demonstration that up-regulation of FoxO3a by paclitaxel can result in increased levels of Bim mRNA and protein, which can be a direct cause of apoptosis in breast cancer cells.
Similar articles
-
Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.Oncogene. 2005 Mar 31;24(14):2317-29. doi: 10.1038/sj.onc.1208421. Oncogene. 2005. PMID: 15688014
-
RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells.J Biol Chem. 2006 Feb 24;281(8):5267-76. doi: 10.1074/jbc.M512151200. Epub 2005 Dec 22. J Biol Chem. 2006. PMID: 16373335
-
Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.Br J Cancer. 2013 Feb 5;108(2):442-9. doi: 10.1038/bjc.2012.563. Epub 2012 Dec 20. Br J Cancer. 2013. PMID: 23257900 Free PMC article.
-
FOXO3a and Its Regulators in Prostate Cancer.Int J Mol Sci. 2021 Nov 20;22(22):12530. doi: 10.3390/ijms222212530. Int J Mol Sci. 2021. PMID: 34830408 Free PMC article. Review.
-
Deciphering the role of forkhead transcription factors in cancer therapy.Curr Drug Targets. 2011 Aug;12(9):1284-90. doi: 10.2174/138945011796150299. Curr Drug Targets. 2011. PMID: 21443462 Free PMC article. Review.
Cited by
-
Forkhead transcription factor FOXO3a protein activates nuclear factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation.J Biol Chem. 2012 May 18;287(21):17737-17745. doi: 10.1074/jbc.M111.291708. Epub 2012 Apr 2. J Biol Chem. 2012. PMID: 22474286 Free PMC article.
-
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo.Oncotarget. 2016 Jul 5;7(27):42110-42125. doi: 10.18632/oncotarget.9881. Oncotarget. 2016. PMID: 27283899 Free PMC article.
-
SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells.Oncogenesis. 2018 Mar 13;7(3):29. doi: 10.1038/s41389-018-0038-6. Oncogenesis. 2018. PMID: 29540677 Free PMC article.
-
Perturbing mitosis for anti-cancer therapy: is cell death the only answer?EMBO Rep. 2018 Mar;19(3):e45440. doi: 10.15252/embr.201745440. Epub 2018 Feb 19. EMBO Rep. 2018. PMID: 29459486 Free PMC article. Review.
-
FOXO3 induces ubiquitylation of AKT through MUL1 regulation.Oncotarget. 2017 Nov 30;8(66):110474-110489. doi: 10.18632/oncotarget.22793. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous